Irbesartan in the Treatment of Hypertensive Patients With Metabolic Syndrome
Status:
Completed
Trial end date:
2007-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this clinical research study is to learn if irbesartan is superior to
hydrochlorothiazide relative to effects on insulin sensitivity and glucose metabolism in
hypertensive patients with metabolic syndrome.